Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR & Cas9 Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR & Cas9 Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR & Cas9 Market Perspective (2018-2033)
2.2 CRISPR & Cas9 Growth Trends by Region
2.2.1 Global CRISPR & Cas9 Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CRISPR & Cas9 Historic Market Size by Region (2018-2023)
2.2.3 CRISPR & Cas9 Forecasted Market Size by Region (2024-2033)
2.3 CRISPR & Cas9 Market Dynamics
2.3.1 CRISPR & Cas9 Industry Trends
2.3.2 CRISPR & Cas9 Market Drivers
2.3.3 CRISPR & Cas9 Market Challenges
2.3.4 CRISPR & Cas9 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR & Cas9 Players by Revenue
3.1.1 Global Top CRISPR & Cas9 Players by Revenue (2018-2023)
3.1.2 Global CRISPR & Cas9 Revenue Market Share by Players (2018-2023)
3.2 Global CRISPR & Cas9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR & Cas9 Revenue
3.4 Global CRISPR & Cas9 Market Concentration Ratio
3.4.1 Global CRISPR & Cas9 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas9 Revenue in 2022
3.5 CRISPR & Cas9 Key Players Head office and Area Served
3.6 Key Players CRISPR & Cas9 Product Solution and Service
3.7 Date of Enter into CRISPR & Cas9 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR & Cas9 Breakdown Data by Type
4.1 Global CRISPR & Cas9 Historic Market Size by Type (2018-2023)
4.2 Global CRISPR & Cas9 Forecasted Market Size by Type (2024-2033)
5 CRISPR & Cas9 Breakdown Data by Application
5.1 Global CRISPR & Cas9 Historic Market Size by Application (2018-2023)
5.2 Global CRISPR & Cas9 Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CRISPR & Cas9 Market Size (2018-2033)
6.2 North America CRISPR & Cas9 Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America CRISPR & Cas9 Market Size by Country (2018-2023)
6.4 North America CRISPR & Cas9 Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR & Cas9 Market Size (2018-2033)
7.2 Europe CRISPR & Cas9 Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe CRISPR & Cas9 Market Size by Country (2018-2023)
7.4 Europe CRISPR & Cas9 Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR & Cas9 Market Size (2018-2033)
8.2 Asia-Pacific CRISPR & Cas9 Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific CRISPR & Cas9 Market Size by Region (2018-2023)
8.4 Asia-Pacific CRISPR & Cas9 Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR & Cas9 Market Size (2018-2033)
9.2 Latin America CRISPR & Cas9 Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America CRISPR & Cas9 Market Size by Country (2018-2023)
9.4 Latin America CRISPR & Cas9 Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR & Cas9 Market Size (2018-2033)
10.2 Middle East & Africa CRISPR & Cas9 Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa CRISPR & Cas9 Market Size by Country (2018-2023)
10.4 Middle East & Africa CRISPR & Cas9 Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Detail
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences CRISPR & Cas9 Introduction
11.1.4 Caribou Biosciences Revenue in CRISPR & Cas9 Business (2018-2023)
11.1.5 Caribou Biosciences Recent Development
11.2 Integrated DNA Technologies(IDT)
11.2.1 Integrated DNA Technologies(IDT) Company Detail
11.2.2 Integrated DNA Technologies(IDT) Business Overview
11.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Introduction
11.2.4 Integrated DNA Technologies(IDT) Revenue in CRISPR & Cas9 Business (2018-2023)
11.2.5 Integrated DNA Technologies(IDT) Recent Development
11.3 CRISPR Therapeutics
11.3.1 CRISPR Therapeutics Company Detail
11.3.2 CRISPR Therapeutics Business Overview
11.3.3 CRISPR Therapeutics CRISPR & Cas9 Introduction
11.3.4 CRISPR Therapeutics Revenue in CRISPR & Cas9 Business (2018-2023)
11.3.5 CRISPR Therapeutics Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck CRISPR & Cas9 Introduction
11.4.4 Merck Revenue in CRISPR & Cas9 Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Mirus Bio
11.5.1 Mirus Bio Company Detail
11.5.2 Mirus Bio Business Overview
11.5.3 Mirus Bio CRISPR & Cas9 Introduction
11.5.4 Mirus Bio Revenue in CRISPR & Cas9 Business (2018-2023)
11.5.5 Mirus Bio Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Detail
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR & Cas9 Introduction
11.6.4 Editas Medicine Revenue in CRISPR & Cas9 Business (2018-2023)
11.6.5 Editas Medicine Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio CRISPR & Cas9 Introduction
11.7.4 Takara Bio Revenue in CRISPR & Cas9 Business (2018-2023)
11.7.5 Takara Bio Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific CRISPR & Cas9 Introduction
11.8.4 Thermo Fisher Scientific Revenue in CRISPR & Cas9 Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Detail
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group CRISPR & Cas9 Introduction
11.9.4 Horizon Discovery Group Revenue in CRISPR & Cas9 Business (2018-2023)
11.9.5 Horizon Discovery Group Recent Development
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Detail
11.10.2 Intellia Therapeutics Business Overview
11.10.3 Intellia Therapeutics CRISPR & Cas9 Introduction
11.10.4 Intellia Therapeutics Revenue in CRISPR & Cas9 Business (2018-2023)
11.10.5 Intellia Therapeutics Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Detail
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies CRISPR & Cas9 Introduction
11.11.4 Agilent Technologies Revenue in CRISPR & Cas9 Business (2018-2023)
11.11.5 Agilent Technologies Recent Development
11.12 Cellecta
11.12.1 Cellecta Company Detail
11.12.2 Cellecta Business Overview
11.12.3 Cellecta CRISPR & Cas9 Introduction
11.12.4 Cellecta Revenue in CRISPR & Cas9 Business (2018-2023)
11.12.5 Cellecta Recent Development
11.13 GenScript
11.13.1 GenScript Company Detail
11.13.2 GenScript Business Overview
11.13.3 GenScript CRISPR & Cas9 Introduction
11.13.4 GenScript Revenue in CRISPR & Cas9 Business (2018-2023)
11.13.5 GenScript Recent Development
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Detail
11.14.2 GeneCopoeia Business Overview
11.14.3 GeneCopoeia CRISPR & Cas9 Introduction
11.14.4 GeneCopoeia Revenue in CRISPR & Cas9 Business (2018-2023)
11.14.5 GeneCopoeia Recent Development
11.15 Synthego
11.15.1 Synthego Company Detail
11.15.2 Synthego Business Overview
11.15.3 Synthego CRISPR & Cas9 Introduction
11.15.4 Synthego Revenue in CRISPR & Cas9 Business (2018-2023)
11.15.5 Synthego Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CRISPR & Cas9 Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic Engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR & Cas9 Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global CRISPR & Cas9 Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global CRISPR & Cas9 Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global CRISPR & Cas9 Market Share by Region (2018-2023)
Table 13. Global CRISPR & Cas9 Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global CRISPR & Cas9 Market Share by Region (2024-2033)
Table 15. CRISPR & Cas9 Market Trends
Table 16. CRISPR & Cas9 Market Drivers
Table 17. CRISPR & Cas9 Market Challenges
Table 18. CRISPR & Cas9 Market Restraints
Table 19. Global CRISPR & Cas9 Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global CRISPR & Cas9 Market Share by Players (2018-2023)
Table 21. Global Top CRISPR & Cas9 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2022)
Table 22. Ranking of Global Top CRISPR & Cas9 Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by CRISPR & Cas9 Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players CRISPR & Cas9 Product Solution and Service
Table 26. Date of Enter into CRISPR & Cas9 Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR & Cas9 Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global CRISPR & Cas9 Revenue Market Share by Type (2018-2023)
Table 30. Global CRISPR & Cas9 Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global CRISPR & Cas9 Revenue Market Share by Type (2024-2033)
Table 32. Global CRISPR & Cas9 Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global CRISPR & Cas9 Revenue Market Share by Application (2018-2023)
Table 34. Global CRISPR & Cas9 Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global CRISPR & Cas9 Revenue Market Share by Application (2024-2033)
Table 36. North America CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America CRISPR & Cas9 Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America CRISPR & Cas9 Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe CRISPR & Cas9 Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe CRISPR & Cas9 Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific CRISPR & Cas9 Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific CRISPR & Cas9 Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific CRISPR & Cas9 Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America CRISPR & Cas9 Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America CRISPR & Cas9 Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa CRISPR & Cas9 Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa CRISPR & Cas9 Market Size by Country (2024-2033) & (US$ Million)
Table 51. Caribou Biosciences Company Detail
Table 52. Caribou Biosciences Business Overview
Table 53. Caribou Biosciences CRISPR & Cas9 Product
Table 54. Caribou Biosciences Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 55. Caribou Biosciences Recent Development
Table 56. Integrated DNA Technologies(IDT) Company Detail
Table 57. Integrated DNA Technologies(IDT) Business Overview
Table 58. Integrated DNA Technologies(IDT) CRISPR & Cas9 Product
Table 59. Integrated DNA Technologies(IDT) Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 60. Integrated DNA Technologies(IDT) Recent Development
Table 61. CRISPR Therapeutics Company Detail
Table 62. CRISPR Therapeutics Business Overview
Table 63. CRISPR Therapeutics CRISPR & Cas9 Product
Table 64. CRISPR Therapeutics Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 65. CRISPR Therapeutics Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck CRISPR & Cas9 Product
Table 69. Merck Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Mirus Bio Company Detail
Table 72. Mirus Bio Business Overview
Table 73. Mirus Bio CRISPR & Cas9 Product
Table 74. Mirus Bio Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 75. Mirus Bio Recent Development
Table 76. Editas Medicine Company Detail
Table 77. Editas Medicine Business Overview
Table 78. Editas Medicine CRISPR & Cas9 Product
Table 79. Editas Medicine Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 80. Editas Medicine Recent Development
Table 81. Takara Bio Company Detail
Table 82. Takara Bio Business Overview
Table 83. Takara Bio CRISPR & Cas9 Product
Table 84. Takara Bio Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 85. Takara Bio Recent Development
Table 86. Thermo Fisher Scientific Company Detail
Table 87. Thermo Fisher Scientific Business Overview
Table 88. Thermo Fisher Scientific CRISPR & Cas9 Product
Table 89. Thermo Fisher Scientific Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 90. Thermo Fisher Scientific Recent Development
Table 91. Horizon Discovery Group Company Detail
Table 92. Horizon Discovery Group Business Overview
Table 93. Horizon Discovery Group CRISPR & Cas9 Product
Table 94. Horizon Discovery Group Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 95. Horizon Discovery Group Recent Development
Table 96. Intellia Therapeutics Company Detail
Table 97. Intellia Therapeutics Business Overview
Table 98. Intellia Therapeutics CRISPR & Cas9 Product
Table 99. Intellia Therapeutics Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 100. Intellia Therapeutics Recent Development
Table 101. Agilent Technologies Company Detail
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies CRISPR & Cas9 Product
Table 104. Agilent Technologies Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 105. Agilent Technologies Recent Development
Table 106. Cellecta Company Detail
Table 107. Cellecta Business Overview
Table 108. Cellecta CRISPR & Cas9 Product
Table 109. Cellecta Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 110. Cellecta Recent Development
Table 111. GenScript Company Detail
Table 112. GenScript Business Overview
Table 113. GenScript CRISPR & Cas9 Product
Table 114. GenScript Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 115. GenScript Recent Development
Table 116. GeneCopoeia Company Detail
Table 117. GeneCopoeia Business Overview
Table 118. GeneCopoeia CRISPR & Cas9 Product
Table 119. GeneCopoeia Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 120. GeneCopoeia Recent Development
Table 121. Synthego Company Detail
Table 122. Synthego Business Overview
Table 123. Synthego CRISPR & Cas9 Product
Table 124. Synthego Revenue in CRISPR & Cas9 Business (2018-2023) & (US$ Million)
Table 125. Synthego Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR & Cas9 Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global CRISPR & Cas9 Market Share by Type: 2022 VS 2033
Figure 3. Genome Editing Features
Figure 4. Genetic Engineering Features
Figure 5. gRNA Database/Gene Librar Features
Figure 6. CRISPR Plasmid Features
Figure 7. Human Stem Cells Features
Figure 8. Genetically Modified Organisms/Crops Features
Figure 9. Cell Line Engineering Features
Figure 10. Global CRISPR & Cas9 Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global CRISPR & Cas9 Market Share by Application: 2022 VS 2033
Figure 12. Biotechnology Companies Case Studies
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Academic Institutes Case Studies
Figure 15. Research and Development Institutes Case Studies
Figure 16. CRISPR & Cas9 Report Years Considered
Figure 17. Global CRISPR & Cas9 Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global CRISPR & Cas9 Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global CRISPR & Cas9 Market Share by Region: 2022 VS 2033
Figure 20. Global CRISPR & Cas9 Market Share by Players in 2022
Figure 21. Global Top CRISPR & Cas9 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by CRISPR & Cas9 Revenue in 2022
Figure 23. North America CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America CRISPR & Cas9 Market Share by Country (2018-2033)
Figure 25. United States CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe CRISPR & Cas9 Market Share by Country (2018-2033)
Figure 29. Germany CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific CRISPR & Cas9 Market Share by Region (2018-2033)
Figure 37. China CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America CRISPR & Cas9 Market Share by Country (2018-2033)
Figure 45. Mexico CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa CRISPR & Cas9 Market Share by Country (2018-2033)
Figure 49. Turkey CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia CRISPR & Cas9 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Caribou Biosciences Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 52. Integrated DNA Technologies(IDT) Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 53. CRISPR Therapeutics Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 55. Mirus Bio Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 56. Editas Medicine Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 57. Takara Bio Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 59. Horizon Discovery Group Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 60. Intellia Therapeutics Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 61. Agilent Technologies Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 62. Cellecta Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 63. GenScript Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 64. GeneCopoeia Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 65. Synthego Revenue Growth Rate in CRISPR & Cas9 Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed